Clomiphene recalls
The FDA has published 2 recalls involving Clomiphene since 2015. The latest was reported on 15 Jun 2022. Most were for potency & assay. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why clomiphene is recalled
Companies
By year
All clomiphene recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | ClomiPHENE Citrate Tablets, USP 50 mg recalled | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | ClomiPHENE Citrate Tablets, USP, 50 mg (2 of each) recalled | EMD Serono | Potency & Assay | Nationwide |
Should you stop taking Clomiphene?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.